Nepafenac

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 9 USDMF, 1 JDMF, 6 EU WC, 10 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 2 FDA Orange Book, 10 Europe, 2 Canada, 2 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.1%

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 1 Ashland, 2 BASF, 1 Curia, 2 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 1 Kima Chemical, 5 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 12 Thickeners and Stabilizers, 11 Taste Masking, 10 Direct Compression, 9 Parenteral, 9 Disintegrants & Superdisintegrants, 9 Solubilizers, 5 Co-Processed Excipients, 5 Rheology Modifiers, 4 Topical, 3 Film Formers & Plasticizers, 3 Granulation, 2 Coating Systems & Additives, 1 Emulsifying Agents, 1 API Stability Enhancers